search
Back to results

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure (PRO-CARF)

Primary Purpose

Covid19

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Awake prone positioning
Standard oxygen therapy
Sponsored by
Hospital Civil de Guadalajara
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Covid19 focused on measuring COVID-19, Severe, Prone positioning, High-flow nasal cannula

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients with confirmed COVID-19, and requirement of a fraction of inspired oxygen (FiO2) ≥30% through high-flow nasal cannula (HFNC) to maintain a capillary saturation of ≥90%

Exclusion Criteria:

  • Less than 18 years-old
  • Pregnancy
  • Patients with immediate need of invasive mechanical ventilation
  • Contraindications for prone positioning therapy
  • Do-not-resuscitate or do-not-intubate order
  • Refusal of the patient or decision maker to enroll in the study

Sites / Locations

  • Hospital Civil Fray Antonio Alcalde
  • Hospital General de Occidente

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard oxygen therapy

Awake prone positioning

Arm Description

Oxygen therapy through high flow nasal cannula (HFNC). Continuous monitoring of vital signs. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%. Prone positioning will be allowed as a rescue therapy.

Oxygen therapy through high flow nasal cannula (HFNC). Patients will be asked to remain in prone position throughout the day as long as possible, with breaks according to tolerance. Pillows will be offered for maximizing comfort at chest, pelvis and knees. Monitoring of vital signs will not be suspended. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%.

Outcomes

Primary Outcome Measures

Intubation rate

Secondary Outcome Measures

Total hours of prone position at day
Total number of prone sessions at day
Hours of the longest prone session each day
Change in oxygenation 1-hour after first prone session
Change in the ROX-index 1-hour after first prone session
The change in the Ratio of Oxygen saturation to respiratory rate (ROX-index)
Total days of prone positioning therapy
Adverse effects of prone positioning therapy
Mechanical ventilation days
Intensive care unit length of stay
Hospital length of stay
Hospital mortality

Full Information

First Posted
July 15, 2020
Last Updated
April 12, 2021
Sponsor
Hospital Civil de Guadalajara
search

1. Study Identification

Unique Protocol Identification Number
NCT04477655
Brief Title
Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure
Acronym
PRO-CARF
Official Title
Prone Positioning in Non-intubated Patients With Severe COVID-19: a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2021
Overall Recruitment Status
Completed
Study Start Date
May 3, 2020 (Actual)
Primary Completion Date
January 26, 2021 (Actual)
Study Completion Date
January 26, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Hospital Civil de Guadalajara

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Besides protective ventilation with low tidal volumes, prone positioning is a proven intervention to decrease mortality in mechanically ventilated patients with moderate-severe acute respiratory distress syndrome. However, the evidence of this strategy in awake non-intubated patients is scarce. The investigators will perform a randomized controlled trial to define if prone positioning can reduce the requirement of mechanical ventilation.
Detailed Description
Despite ongoing trials of antivirals and immunomodulatory therapies against COVID-19, the treatment of moderate/severe disease is mainly supportive, including oxygen therapy and invasive mechanical ventilation when impending respiratory failure is established. Moreover, the associated mortality among mechanically intubated patients is overwhelmingly high. Prone position relieves the dependent lung regions from the compressive forces of the mediastinum's weight, leading to homogenization of the gas:tissue ratio between ventral and dorsal lung regions. According to a few case series, and observational non-randomized studies with small sample sizes, there is a consistent improvement in oxygenation in COVID-19 patients during prone positioning, however there are no clinical evidence that this improvement is associated with a decrease in the risk of invasive mechanical ventilation. Considering that prone positioning is a low cost, low risk and widely available therapy, more high quality evidence is needed, to determine if the benefits of prone positioning in awake patients also include a lower requirement of mechanical ventilation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Covid19
Keywords
COVID-19, Severe, Prone positioning, High-flow nasal cannula

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
430 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Standard oxygen therapy
Arm Type
Active Comparator
Arm Description
Oxygen therapy through high flow nasal cannula (HFNC). Continuous monitoring of vital signs. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%. Prone positioning will be allowed as a rescue therapy.
Arm Title
Awake prone positioning
Arm Type
Experimental
Arm Description
Oxygen therapy through high flow nasal cannula (HFNC). Patients will be asked to remain in prone position throughout the day as long as possible, with breaks according to tolerance. Pillows will be offered for maximizing comfort at chest, pelvis and knees. Monitoring of vital signs will not be suspended. Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%.
Intervention Type
Procedure
Intervention Name(s)
Awake prone positioning
Intervention Description
Patients will be asked to remain in prone position or lateral decubitus throughout the day as long as possible.
Intervention Type
Procedure
Intervention Name(s)
Standard oxygen therapy
Intervention Description
Oxygen therapy through high flow nasal cannula (HFNC). Inspired fraction of oxygen will be titrated to maintain a capillary saturation of ≥92%
Primary Outcome Measure Information:
Title
Intubation rate
Time Frame
28 days
Secondary Outcome Measure Information:
Title
Total hours of prone position at day
Time Frame
28 days
Title
Total number of prone sessions at day
Time Frame
28 days
Title
Hours of the longest prone session each day
Time Frame
28 days
Title
Change in oxygenation 1-hour after first prone session
Time Frame
1 hour
Title
Change in the ROX-index 1-hour after first prone session
Description
The change in the Ratio of Oxygen saturation to respiratory rate (ROX-index)
Time Frame
1 hour
Title
Total days of prone positioning therapy
Time Frame
28 days
Title
Adverse effects of prone positioning therapy
Time Frame
28 days
Title
Mechanical ventilation days
Time Frame
28 days
Title
Intensive care unit length of stay
Time Frame
28 days
Title
Hospital length of stay
Time Frame
28 days
Title
Hospital mortality
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients with confirmed COVID-19, and requirement of a fraction of inspired oxygen (FiO2) ≥30% through high-flow nasal cannula (HFNC) to maintain a capillary saturation of ≥90% Exclusion Criteria: Less than 18 years-old Pregnancy Patients with immediate need of invasive mechanical ventilation Contraindications for prone positioning therapy Do-not-resuscitate or do-not-intubate order Refusal of the patient or decision maker to enroll in the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Miguel Ibarra-Estrada
Organizational Affiliation
Investigator
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Civil Fray Antonio Alcalde
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44280
Country
Mexico
Facility Name
Hospital General de Occidente
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
45170
Country
Mexico

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35346319
Citation
Ibarra-Estrada M, Li J, Pavlov I, Perez Y, Roca O, Tavernier E, McNicholas B, Vines D, Marin-Rosales M, Vargas-Obieta A, Garcia-Salcido R, Aguirre-Diaz SA, Lopez-Pulgarin JA, Chavez-Pena Q, Mijangos-Mendez JC, Aguirre-Avalos G, Ehrmann S, Laffey JG. Factors for success of awake prone positioning in patients with COVID-19-induced acute hypoxemic respiratory failure: analysis of a randomized controlled trial. Crit Care. 2022 Mar 28;26(1):84. doi: 10.1186/s13054-022-03950-0.
Results Reference
derived
PubMed Identifier
34425070
Citation
Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E; Awake Prone Positioning Meta-Trial Group. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 Dec;9(12):1387-1395. doi: 10.1016/S2213-2600(21)00356-8. Epub 2021 Aug 20.
Results Reference
derived
PubMed Identifier
33225990
Citation
Ibarra-Estrada MA, Marin-Rosales M, Garcia-Salcido R, Aguirre-Diaz SA, Vargas-Obieta A, Chavez-Pena Q, Lopez-Pulgarin JA, Mijangos-Mendez JC, Aguirre-Avalos G. Prone positioning in non-intubated patients with COVID-19 associated acute respiratory failure, the PRO-CARF trial: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 23;21(1):940. doi: 10.1186/s13063-020-04882-2.
Results Reference
derived

Learn more about this trial

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure

We'll reach out to this number within 24 hrs